PRA Health Sciences (PRA) (NASDAQ: PRAH) a leading global contract research organization, is expanding its presence in Pennsylvania. Employees recently relocated from the company's Horsham and Fort Washington facilities to PRA's new modern Class A+ office space in Blue Bell, now the company's largest office worldwide. PRA currently has more than one thousand employees in Pennsylvania and is looking to add additional staff.

"We are delighted to be in this beautiful new space and we look forward to welcoming more talented individuals to join our team," said Harris Koffer, President of the Strategic Solutions Group at PRA. "This new facility is a testament to PRA's continued growth and our commitment to our clients and the surrounding community."

PRA is hiring across all major divisions, including clinical operations areas and corporate functions. Currently 150 positions are available at the Blue Bell office and surrounding areas. Information about PRA career opportunities can be found at

To date, PRA has invested nearly $4 million dollars in the Blue Bell expansion project. The project is expected to create at least 250 new full-time jobs by the end of 2016, and will retain 1,150 existing employees. Based on the project's significant economic impact, the Pennsylvania Department of Community and Economic Development (DCED) provided PRA with a $750,000 Pennsylvania First Program (PFP) grant.

"The life science industry is a major driver of economic growth for the commonwealth," said DCED Secretary Dennis Davin. "PRA Health Sciences has shown a commitment to remain a part of this growth and we're thrilled that the company will be creating at least 250 new, high-paying jobs through this project."

The PRA Blue Bell office is located at 731 Arbor Way. The facility includes state-of-the-art shared tenant conference space, staff workplace benefits, and a fitness center. With 148,000 square feet, the building can accommodate approximately 860 PRA employees.


At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 11,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions™ model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. PRA has worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.